APA (7th ed.) Citation

Morcos, P. N., Schlender, J., Burghaus, R., Moss, J., Lloyd, A., Childs, B. H., . . . Garmann, D. (2023). Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. CTS: Clinical & Translational Science, 16(7), 1197. https://doi.org/10.1111/cts.13523

Chicago Style (17th ed.) Citation

Morcos, Peter N., et al. "Model‐informed Approach to Support Pediatric Dosing for the Pan‐PI3K Inhibitor Copanlisib in Children and Adolescents with Relapsed/refractory Solid Tumors." CTS: Clinical & Translational Science 16, no. 7 (2023): 1197. https://doi.org/10.1111/cts.13523.

MLA (9th ed.) Citation

Morcos, Peter N., et al. "Model‐informed Approach to Support Pediatric Dosing for the Pan‐PI3K Inhibitor Copanlisib in Children and Adolescents with Relapsed/refractory Solid Tumors." CTS: Clinical & Translational Science, vol. 16, no. 7, 2023, p. 1197, https://doi.org/10.1111/cts.13523.